Learn more about IMRIS neurosurgical imaging products at booth #2013
WINNIPEG, April 22, 2013 /PRNewswire/ - IMRIS, Inc. (NASDAQ: IMRS; TSX: IM)
("IMRIS" or the "Company") today announced that it will exhibit its
novel intraoperative CT solution with state-of-the-art imaging that is
currently under development at the American Association of Neurological
Surgeons (AANS) Annual Scientific Meeting, April 27-May 1, in New
Attendees are invited to visit the IMRIS booth (#2013) in the exhibition
hall to learn more about its integrated VISIUS® iMRI and VISIUS iCT products. (VISIUS iCT is pending US FDA 510(k)
approval and is not available for sale in any market.)
Like the VISIUS® Surgical Theatre with iMRI, the VISIUS iCT will move on-demand using
ceiling-mounted rails for effortless access in the OR so no patient
transport is required for imaging. The multifunctional environment
eliminates space compromises of floor rail or wheeled portable systems
to optimize workflow and may improve surgical outcomes. Developed for
cranial and spinal surgery, the system is also intended to provide
physicians with advanced image quality with access to a full range of
software applications for intelligent dosing.
The IMRIS comprehensive and interactive AANS booth will also have on
display its latest neurosurgical advancements in robotics with the
SYMBIS Surgical System, operating room tables, head fixation devices
and imaging coils. (The SYMBIS Surgical System is FDA 510(k) pending
and not available for sale in any market.)
The central theme of the AANS 2013 educational sessions relates to
advancing patient safety. Scheduled presentations by faculty members
will be an opportunity to demonstrate the current and future impact of
intraoperative MRI and CT imaging in cranial and spinal neurosurgery.
Clinical studies show that transporting patients for intraoperative
imaging - even a short distance - poses risks related to the movement
of monitoring equipment, cardiac and respiratory issues, and workflow
and positioning ramifications.
VISIUS Surgical Theatre systems are intended to limit compromising
patient risk in the neurosurgical environment by eliminating patient
transport and maintaining patient positioning throughout surgical
procedures. This true intraoperative advantage preserves established
surgical access and techniques while assisting in critical
decision-making and enhancing treatment precision.
IMRIS (NASDAQ: IMRS; TSX: IM) is a global leader in providing image
guided therapy solutions through its VISIUS Surgical Theatre - a
revolutionary, multifunctional surgical environment that provides
unmatched intraoperative vision to clinicians to assist in decision
making and enhance precision in treatment. VISIUS Surgical Theatres
serve the neurosurgical, cardiovascular and cerebrovascular markets and
have been selected by leading medical institutions around the world.
SOURCE IMRIS Inc.
Help employers find you! Check out all the jobs and post your resume.